| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
ProPhase Labs (NASDAQ:PRPH) is set to give its latest quarterly earnings report on Wednesday, 2025-08-13. Here's what investors need to know before the announcement.
Analysts estimate that ProPhase Labs will report an earnings per share (EPS) of $-0.15.
ProPhase Labs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
The company's EPS beat by $0.05 in the last quarter, leading to a 12.42% drop in the share price on the following day.
Here's a look at ProPhase Labs's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.18 | -1.27 | 0.04 | -0.24 |
| EPS Actual | -0.13 | -1.59 | -0.35 | -0.33 |
| Price Change % | -12.0% | -0.0% | -2.0% | -10.0% |
Shares of ProPhase Labs were trading at $0.2817 as of August 11. Over the last 52-week period, shares are down 85.7%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for ProPhase Labs visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: PRPH
